CHARACTERISTICS AND OUTCOMES OF PATIENTS WITH RELAPSED FOLLICULAR LYMPHOMA FOLLOWING RETREATMENT WITH SECOND‐LINE RITUXIMAB‐CONTAINING CHEMOTHERAPY. (12th June 2019) - Liu, J.; Biccler, J.L.; Stewart, D.; Fontaine, A.; Peters, A.; Fleury, I.; Mollica, L.; Prica, A.; Buckstein, R.; Kuruvilla, J.; Villa, D.